Tag Archives: AFSI

Top 5 Undervalued Stocks For 2019

Inmarsat Plc rose as much as 12 percent after the British satellite company last week said it had rebuffed a takeover proposal from EchoStar Corp.

A “highly preliminary” offer was turned down by the board after discussions with its advisers, Inmarsat said in a statement on Friday. “It very significantly undervalued Inmarsat and its stand-alone prospects. The board remains highly confident in the independent strategy and prospects of Inmarsat.”

The stock rose 11 percent to 525 in early trading in London on Monday. The statement from Inmarsat on Friday followed a 13 percent surge in its shares, the most in a decade.

#lazy-img-328479334:before{padding-top:56.25%;}

EchoStar, founded by billionaire Charlie Ergen, has long been seen as a potential bidder for Inmarsat, along with SoftBank Group Corp.’s OneWeb. A stock slump at the London-based company has put it at the top of analysts’ lists of potential targets for consolidation in the satellite industry, which is becoming increasingly crowded with a rising number of rigs going up to support new services such as in-flight Wi-Fi and transmission of digital photos.

Top 5 Undervalued Stocks For 2019: ING Group, N.V.(ISP)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Intesa Sanpaolo (BIT:ISP) has been given a €2.15 ($2.50) target price by stock analysts at UBS Group in a research note issued on Tuesday, www.boersen-zeitung.de reports. The firm presently has a “neutral” rating on the stock.

  • [By Max Byerly]

    Intesa Sanpaolo (BIT:ISP) received a €3.00 ($3.53) price target from stock analysts at HSBC in a research report issued to clients and investors on Thursday. The brokerage presently has a “buy” rating on the stock. HSBC’s target price points to a potential downside of 2.60% from the stock’s current price.

  • [By Stephan Byrd]

    Goldman Sachs Group set a €2.90 ($3.37) price target on Intesa Sanpaolo (BIT:ISP) in a report published on Wednesday. The firm currently has a neutral rating on the stock.

  • [By Stephan Byrd]

    Intesa Sanpaolo (BIT:ISP) received a €2.90 ($3.37) price target from research analysts at Deutsche Bank in a research note issued to investors on Wednesday. The firm presently has a “buy” rating on the stock.

  • [By Logan Wallace]

    Berenberg Bank set a €2.20 ($2.56) price target on Intesa Sanpaolo (BIT:ISP) in a research report sent to investors on Wednesday. The brokerage currently has a neutral rating on the stock.

Top 5 Undervalued Stocks For 2019: Curis, Inc.(CRIS)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Euro Tech Holdings Company Limited (NASDAQ: CLWT) rose 18.2 percent to $4.55 in pre-market trading after the company declared a $0.70 per share special dividend.
    Co-Diagnostics, Inc. (NASDAQ: CODX) rose 11.7 percent to $3.24 in pre-market trading after falling 13.17 percent on Thursday. Co-Diagnostics reported its participation in a research project with the Stanford University.
    Abercrombie & Fitch Co. (NYSE: ANF) shares rose 8.6 percent to $25.95 in pre-market trading after the company posted upbeat Q1 results.
    Zuora, Inc. (NYSE: ZUO) shares rose 8 percent to $23.95 in pre-market trading after the company reported upbeat Q1 earnings and issued strong outlook.
    Lululemon Athletica Inc. (NASDAQ: LULU) shares rose 7.8 percent to $113.25 in pre-market trading after the company reported better-than-expected results for its first quarter. The company also raised its FY18 earnings and sales guidance.
    OPKO Health, Inc. (NYSE: OPK) rose 5.7 percent to $4.10 in pre-market trading.
    Lannett Company, Inc. (NYSE: LCI) rose 5.5 percent to $17.45 in pre-market trading following the FDA approval for Levofloxacin Oral Solution.
    Eversource Energy (NYSE: ES) shares rose 5 percent to $59.8 in pre-market trading.
    VMware, Inc. (NYSE: VMW) rose 4.6 percent to $143.74 in pre-market trading as the company reported stronger-than-expected results for its first quarter on Thursday.
    Energy Transfer Partners, L.P. (NYSE: ETP) rose 4.3 percent to $19.80 in pre-market trading after the company reported the Federal Energy Regulatory Commission approval to place Rover pipeline’s full Mainline B into service.
    T2 Biosystems, Inc. (NASDAQ: TTOO) rose 4.3 percent to $7.73 in pre-market trading after declining 4.26 percent on Thursday.
    Curis, Inc. (NASDAQ: CRIS) rose 4.3 percent to $2.90 in pre-market trading after jumping 21.93 percent on Thursday.
    Sasol Limited (NYSE: SSL) rose 4.2 percent to $37.91 in pre-market trading.
    Nucor Corporatio
  • [By Lisa Levin] Gainers
    Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) shares surged 144.96 percent to close at $265.61 on Thursday in reaction to an encouraging Phase 2 clinical trial update. The clinical-stage biopharmaceutical company said its liver-directed, thyroid hormone receptor called MGL-3196 showed a statistical significance in the primary endpoint of lowering liver fat at 12 weeks and also 36 weeks.
    Viking Therapeutics, Inc. (NASDAQ: VKTX) shares rose 101.01 percent to close at $9.99 on Thursday after falling 4.42 percent on Wednesday.
    Akers Biosciences, Inc. (NASDAQ: AKER) jumped 45.58 percent to close at $0.474. The developer of rapid health information technologies said Wednesday afternoon it was granted a 180-day extension from the Nasdaq Stock Market to meet the requirement of a minimum $1.00 per share closing bid price for 10 straight days.
    Kitov Pharma Ltd (NASDAQ: KTOV) gained 40.93 percent to close at $3.03 after the FDA approved Kitov's Consensi for the treatment of osteoarthritis pain and hypertension.
    China Customer Relations Centers, Inc. (NASDAQ: CCRC) rose 28.21 percent to close at $19.86.
    J.Jill, Inc. (NYSE: JILL) climbed 26.45 percent to close at $7.84 after the company posted upbeat quarterly earnings.
    Curis, Inc. (NASDAQ: CRIS) shares climbed 21.93 percent to close at $2.78 in reaction to an encouraging FDA update. The biotechnology company that focuses on therapies for the treatment of cancer said the FDA granted a Fast Track designation for fimepinostat (CUDC-907) in patients with relapsed or refractory.
    Boxlight Corporation (NASDAQ: BOXL) gained 21.23 percent to close at $7.48.
    Kirkland's, Inc. (NASDAQ: KIRK) rose 16.21 percent to close at $12.83 after reporting upbeat Q1 results.
    The Brink's Company (NYSE: BCO) jumped 16.2 percent to close at $79.25 as the company announced plans to acquire Dunbar Armored for $520 million in cash.
    Applied Optoelectronics, Inc. (NASDAQ: AAOI) rose 15.14 percent to c
  • [By Lisa Levin] Gainers
    Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) jumped 124.8 percent to $243.725 in reaction to an encouraging Phase 2 clinical trial update. The clinical-stage biopharmaceutical company said its liver-directed, thyroid hormone receptor called MGL-3196 showed a statistical significance in the primary endpoint of lowering liver fat at 12 weeks and also 36 weeks.
    Viking Therapeutics, Inc. (NASDAQ: VKTX) gained 63.4 percent to $8.12 after falling 4.42 percent on Wednesday.
    Takung Art Co., Ltd. (NYSE: TKAT) rose 43.3 percent to $2.9094
    vTv Therapeutics Inc. (NASDAQ: VTVT) shares climbed 29.7 percent to $2.16 after the company reported a licensing deal with Newsoara Biopharma to rights for vTv's PDE4 Inhibitor in China and other Pacific Rim territories.
    Akers Biosciences, Inc. (NASDAQ: AKER) gained 26.2 percent to $0.4109. The developer of rapid health information technologies said Wednesday afternoon it was granted a 180-day extension from the Nasdaq Stock Market to meet the requirement of a minimum $1.00 per share closing bid price for 10 straight days.
    Genprex, Inc. (NASDAQ: GNPX) rose 22.2 percent to $11.6254. Genprex reported engagement of WIRB-Copernicus Group to provide clinical trial services to support Oncoprex clinical trial program.
    J.Jill, Inc. (NYSE: JILL) gained 21 percent to $7.506 after the company posted upbeat quarterly earnings.
    Urban One, Inc. (NASDAQ: UONE) gained 19.7 percent to $3.95 after rising 78.38 percent on Wednesday.
    TapImmune, Inc. (NASDAQ: TPIV) shares gained 18.5 percent to $6.03 after climbing 24.15 percent on Wednesday.
    Kirkland's, Inc. (NASDAQ: KIRK) rose 17.3 percent to $12.95 after reporting upbeat Q1 results.
    CymaBay Therapeutics, Inc. (NASDAQ: CBAY) shares gained 15.1 percent to $13.210.
    The Brink's Company (NYSE: BCO) climbed 14.2 percent to $77.875 as the company announced plans to acquire Dunbar Armored for $520 million in cash.
    Keysight Technologies, Inc. (NYSE: KEY

Top 5 Undervalued Stocks For 2019: AmTrust Financial Services, Inc.(AFSI)

Advisors’ Opinion:

  • [By Logan Wallace]

    A number of firms have modified their ratings and price targets on shares of AmTrust Financial Services (NASDAQ: AFSI) recently:

    8/16/2018 – AmTrust Financial Services was upgraded by analysts at BidaskClub from a “sell” rating to a “hold” rating. 8/9/2018 – AmTrust Financial Services was downgraded by analysts at BidaskClub from a “hold” rating to a “sell” rating. 8/7/2018 – AmTrust Financial Services had its price target raised by analysts at B. Riley from $12.00 to $14.75. They now have a “neutral” rating on the stock. 7/31/2018 – AmTrust Financial Services was upgraded by analysts at BidaskClub from a “sell” rating to a “hold” rating. 7/18/2018 – AmTrust Financial Services was downgraded by analysts at BidaskClub from a “hold” rating to a “sell” rating. 7/18/2018 – AmTrust Financial Services had its “$14.58” rating reaffirmed by analysts at Keefe, Bruyette & Woods. They now have a $14.75 price target on the stock. 7/10/2018 – AmTrust Financial Services was downgraded by analysts at BidaskClub from a “buy” rating to a “hold” rating. 6/18/2018 – AmTrust Financial Services was upgraded by analysts at Zacks Investment Research from a “strong sell” rating to a “hold” rating. According to Zacks, “AmTrust has agreed to go private as Evergreen Parent will buy 45% of the company’s stake which Karfunkel-Zyskind Family does not own presently for $2.7 billion. This acquisition will help AmTrust focus on long term growth objective rather than on short term results given it is becoming a private company. AmTrust’s leadership position in commercial small business, expansion of other segments and an impressive inorganic growth story poise it well for growth. It also aims to build an investment portfolio that returns in line with

  • [By Ethan Ryder]

    Keefe, Bruyette & Woods reissued their $14.58 rating on shares of AmTrust Financial Services (NASDAQ:AFSI) in a research report report published on Wednesday. They currently have a $14.75 price target on the insurance provider’s stock.

  • [By Lisa Levin] Gainers
    Shineco, Inc. (NASDAQ: TYHT) rose 34.7 percent to $2.29 in pre-market trading following Q3 results. Shineco posted Q3 earnings of $0.21 per share on sales of $13.3 million.
    Carver Bancorp, Inc. (NASDAQ: CARV) rose 15.8 percent to $12.74 in pre-market trading after surging 201.37 percent on Thursday.
    LiveXLive Media, Inc. (NASDAQ: LIVX) shares rose 11.5 percent to $7.75 in pre-market trading after climbing 64.50 percent on Thursday.
    Eiger BioPharmaceuticals, Inc. (NASDAQ: EIGR) rose 9 percent to $18.30 in pre-market trading after climbing 41.77 percent on Thursday.
    AmTrust Financial Services Inc (NASDAQ: AFSI) rose 6.2 percent to $14.25 in pre-market trading after a 13D filing from Carl Icahn shows a new 9.38 percent stake in the company. The filing also shows language from Icahn that strongly opposes a go-private transaction.
    Cerner Corporation (NASDAQ: CERN) rose 5.6 percent to $64.02 in pre-market trading after the Department of Veterans Affairs reported an agreement with Cerner Government Services, Inc. to provide seamless care for veterans.
    PetroChina Company Limited (NYSE: PTR) shares rose 5.3 percent to $82.05 in pre-market trading.
    TC PipeLines, LP (NYSE: TCP) shares rose 5.2 percent to $26.59 in the pre-market trading session.
    IQVIA Holdings Inc. (NYSE: IQV) shares rose 4.8 percent to $102.50 in pre-market trading as the company pulled secondary offering 'in light of recent market conditions'.
    Axon Enterprise, Inc. (NASDAQ: AAXN) rose 4.5 percent to $59.70 in pre-market trading. On Thursday, Axon priced its 4.3 million share offering of common stock at $53 per share.
    The Trade Desk, Inc. (NASDAQ: TTD) rose 4.5 percent to $84 in pre-market trading.
    PetIQ Inc (NASDAQ: PETQ) rose 3.9 percent to $18.96 in pre-market trading after a 13G filing shows a new 5.05 percent stake by the State of New Jersey's Division of Investment.
    Mattel, Inc. (NASDAQ: MAT) shares rose 3.7 percent to $15.85 in pre-market

Top 5 Undervalued Stocks For 2019: Aspen Insurance Holdings Limited(AHL)

Advisors’ Opinion:

  • [By Ethan Ryder]

    ValuEngine upgraded shares of Aspen Insurance (NYSE:AHL) from a sell rating to a hold rating in a research report released on Thursday morning.

    Separately, Zacks Investment Research cut shares of Aspen Insurance from a hold rating to a strong sell rating in a research report on Thursday, April 19th. Four investment analysts have rated the stock with a hold rating and one has assigned a buy rating to the company. The company presently has an average rating of Hold and a consensus price target of $43.50.

  • [By Ethan Ryder]

    Aspen Insurance (NYSE: AHL) and Tokio Marine Holdings, Inc. Sponsored ADR common stock (OTCMKTS:TKOMY) are both finance companies, but which is the superior stock? We will contrast the two businesses based on the strength of their earnings, profitability, valuation, risk, dividends, analyst recommendations and institutional ownership.

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Aspen Insurance (AHL)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 5 Undervalued Stocks For 2019: Williams-Sonoma Inc.(WSM)

Advisors’ Opinion:

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Williams-Sonoma (WSM)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    Williams-Sonoma, Inc. (NYSE:WSM) was the target of unusually large options trading on Thursday. Stock investors acquired 7,037 put options on the stock. This is an increase of approximately 1,152% compared to the typical volume of 562 put options.

  • [By Motley Fool Staff]

    Williams Sonoma (NYSE:WSM) Q1 2018 Earnings Conference CallMay. 23, 2018 5:00 p.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

Hot Warren Buffett Stocks For 2019

When will the world see its first trillionaire? A British charity estimates that it could happen within 25 years and that it will be none other than Microsoft founder Bill Gates.

Oxfam, the U.K. world hunger organization, meant to shame the world’s richest with its list of multi-billionaires. Which is odd, considering that Gates is a founder, with Warren Buffett, of The Giving Pledge and has spent billions through his foundation fighting tropical disease and hunger.

Hot Warren Buffett Stocks For 2019: tronc, Inc. (TRNC)

Advisors’ Opinion:

  • [By Elizabeth Balboa]

    Lee Enterprises, Incorporated (NYSE: LEE), tronc Inc (NASDAQ: TRNC) and A&E Networks — a subsidiary of Walt Disney Co (NYSE: DIS) — were found to have forgone the costly risk of violating GDPR and pulled out of the European market altogether.

  • [By Douglas A. McIntyre]

    Tronc Inc. (NASDAQ: TRNC), the owner of the Lost Angeles Times, agreed to sell the paper to billionaire Patrick Soon-Shiong, who is also one of Tronc’s largest shareholders. The deal, for $500 million and the assumption of about $90 million in pension liabilities, was announced on February 7. The Federal Trade Commission and U.S. Department of Justice blessed the deal on March 7, almost two months ago.

  • [By Douglas A. McIntyre]

    Several large newspaper chains will face the largest increases in newsprint prices in absolute dollars. These are Gannett (NYSE: GCI), tronc (NASDAQ: TRNC), hedge fund owned Digital First Media, which just laid off dozens of people in Denver and on the West Coast, Hearst, Advance Media, McClatchy (NYSE: MNI) and Gatehouse Media. Among them, they own most of the large newspapers in America and hundreds of newspapers in aggregate. Each of these companies has newsprint demand much larger than that of The Tampa Bay Times.

  • [By Douglas A. McIntyre]

    An arrangement for the largest shareholder of publisher Tronc Inc. (NASDAQ: TRNC) to sell his stock will not go through. According to The Wall Street Journal:

  • [By Chris Hill]

    Unemployment hits a 49-year low. Tech giants may have been hacked by China. Elon Musk’s tweeting sends Tesla (NASDAQ:TSLA) shares lower. Costco (NASDAQ:COST) struggles with “material weakness.” And Tronc (NASDAQ:TRNC) decides to change its name back to Tribune Publishing.

  • [By Douglas A. McIntyre]

    The sale of the Los Angeles Times and several smaller newspapers by Tronc Inc. (NASDAQ: TRNC) to Dr. Patrick Soon-Shiong closed after months of worry.

Hot Warren Buffett Stocks For 2019: Castlight Health, inc.(CSLT)

Advisors’ Opinion:

  • [By Logan Wallace]

    Castlight Health Inc (NYSE:CSLT) has been given an average rating of “Buy” by the eight ratings firms that are covering the firm, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, two have given a hold recommendation and five have given a buy recommendation to the company. The average 12 month price target among analysts that have issued a report on the stock in the last year is $5.56.

  • [By Joseph Griffin]

    Gagnon Advisors LLC grew its stake in shares of Castlight Health Inc (NYSE:CSLT) by 29.7% during the 2nd quarter, HoldingsChannel reports. The firm owned 1,169,056 shares of the software maker’s stock after acquiring an additional 267,662 shares during the period. Castlight Health makes up approximately 3.1% of Gagnon Advisors LLC’s portfolio, making the stock its 17th largest position. Gagnon Advisors LLC’s holdings in Castlight Health were worth $4,968,000 at the end of the most recent reporting period.

  • [By Ethan Ryder]

    Castlight Health Inc (NYSE:CSLT) shot up 2.6% on Monday . The stock traded as high as $3.10 and last traded at $2.97. 6,914 shares traded hands during mid-day trading, a decline of 99% from the average session volume of 535,927 shares. The stock had previously closed at $3.05.

  • [By Max Byerly]

    Zendesk (NYSE: ZEN) and Castlight Health (NYSE:CSLT) are both computer and technology companies, but which is the superior stock? We will contrast the two companies based on the strength of their dividends, risk, earnings, profitability, valuation, analyst recommendations and institutional ownership.

  • [By Stephan Byrd]

    Fmr LLC grew its holdings in shares of Castlight Health Inc (NYSE:CSLT) by 2.1% during the second quarter, Holdings Channel reports. The institutional investor owned 12,620,881 shares of the software maker’s stock after buying an additional 254,616 shares during the period. Fmr LLC owned 0.09% of Castlight Health worth $53,639,000 at the end of the most recent quarter.

Hot Warren Buffett Stocks For 2019: California Resources Corporation(CRC)

Advisors’ Opinion:

  • [By Logan Wallace]

    Here is how similar cryptocurrencies have performed during the last day:

    Get CrowdCoin alerts:

    Feathercoin (FTC) traded 0% higher against the dollar and now trades at $0.0551 or 0.00000785 BTC. GoByte (GBX) traded up 6.4% against the dollar and now trades at $0.93 or 0.00013253 BTC. Uniform Fiscal Object (UFO) traded 4.4% higher against the dollar and now trades at $0.0004 or 0.00000005 BTC. Innova (INN) traded 4.4% lower against the dollar and now trades at $0.12 or 0.00001757 BTC. CryCash (CRC) traded down 5.8% against the dollar and now trades at $0.11 or 0.00001587 BTC. Guncoin (GUN) traded up 6% against the dollar and now trades at $0.0015 or 0.00000021 BTC. Sparks (SPK) traded 3.5% lower against the dollar and now trades at $0.0278 or 0.00000397 BTC. IPChain (IPC) traded down 6.7% against the dollar and now trades at $0.18 or 0.00002593 BTC.

    CrowdCoin Coin Profile

  • [By Joseph Griffin]

    Here is how other cryptocurrencies have performed in the last 24 hours:

    Get CryCash alerts:

    Feathercoin (FTC) traded 8.3% higher against the dollar and now trades at $0.0566 or 0.00000892 BTC. GoByte (GBX) traded up 1.9% against the dollar and now trades at $1.33 or 0.00020933 BTC. Uniform Fiscal Object (UFO) traded 6.7% lower against the dollar and now trades at $0.0003 or 0.00000005 BTC. Innova (INN) traded up 5.6% against the dollar and now trades at $0.0889 or 0.00001400 BTC. Guncoin (GUN) traded down 6.8% against the dollar and now trades at $0.0010 or 0.00000015 BTC. Sparks (SPK) traded 51% higher against the dollar and now trades at $0.0526 or 0.00000829 BTC. CrowdCoin (CRC) traded 7.9% lower against the dollar and now trades at $0.0254 or 0.00000400 BTC. IPChain (IPC) traded down 2% against the dollar and now trades at $0.28 or 0.00004389 BTC.

    About CryCash

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on California Resources (CRC)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Hot Warren Buffett Stocks For 2019: NVIDIA Corporation(NVDA)

Advisors’ Opinion:

  • [By Danny Vena]

    Over the last several years, NVIDIA (NASDAQ:NVDA) has been on a tear, fueled by higher demand for its industry-leading graphics processing units (GPUs). The ranks of casual gamers have been growing, and wider adoption of the company’s processors for artificial intelligence (AI) systems has opened up a whole new area of growth for the company. The stock has soared, up nearly 1,000% over the past three years and up 65% so far in 2018.

  • [By Anders Bylund]

    NVIDIA (NASDAQ:NVDA) published a business update on Thursday evening, covering the second quarter of the company’s fiscal 2019. The designer of graphics processors and other high-performance number-crunching chips enjoyed strong data center sales while cryptocurrency mining fell right off the map.

  • [By Timothy Green]

    Graphics chip leader NVIDIA (NASDAQ:NVDA) will report its fourth-quarter results after the market closes on Thursday. The company is dealing with a litany of problems that will put an end to its impressive growth streak, including excess gaming GPU inventory, weak sales of its latest graphics cards, a data center slowdown, and sluggish demand from China. The company’s guidance is unlikely to be any better than its results.

  • [By Daniel Sparks]

    Two of the most intriguing stories in tech this week include the impressive success of Square’s (NYSE:SQ) Cash App — a peer-to-peer payment service — and chipmaker NVIDIA’s (NASDAQ:NVDA) earnings. Headlines for both companies sent their stocks in opposite directions.

  • [By Chris Lange]

    Look for Nvidia Corp. (NASDAQ: NVDA) to release its most recent quarterly results late on Thursday. The consensus forecast calls for $1.40 in EPS and $2.7 billion in revenue for the fourth quarter. Shares closed most recently at $148.17. The consensus price target is $227.18, and shares have traded between $124.46 and $292.76 in the past 52 weeks.

Hot Warren Buffett Stocks For 2019: AmTrust Financial Services, Inc.(AFSI)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Keefe, Bruyette & Woods reissued their $14.58 rating on shares of AmTrust Financial Services (NASDAQ:AFSI) in a research report report published on Wednesday. They currently have a $14.75 price target on the insurance provider’s stock.

  • [By Logan Wallace]

    A number of firms have modified their ratings and price targets on shares of AmTrust Financial Services (NASDAQ: AFSI) recently:

    8/16/2018 – AmTrust Financial Services was upgraded by analysts at BidaskClub from a “sell” rating to a “hold” rating. 8/9/2018 – AmTrust Financial Services was downgraded by analysts at BidaskClub from a “hold” rating to a “sell” rating. 8/7/2018 – AmTrust Financial Services had its price target raised by analysts at B. Riley from $12.00 to $14.75. They now have a “neutral” rating on the stock. 7/31/2018 – AmTrust Financial Services was upgraded by analysts at BidaskClub from a “sell” rating to a “hold” rating. 7/18/2018 – AmTrust Financial Services was downgraded by analysts at BidaskClub from a “hold” rating to a “sell” rating. 7/18/2018 – AmTrust Financial Services had its “$14.58” rating reaffirmed by analysts at Keefe, Bruyette & Woods. They now have a $14.75 price target on the stock. 7/10/2018 – AmTrust Financial Services was downgraded by analysts at BidaskClub from a “buy” rating to a “hold” rating. 6/18/2018 – AmTrust Financial Services was upgraded by analysts at Zacks Investment Research from a “strong sell” rating to a “hold” rating. According to Zacks, “AmTrust has agreed to go private as Evergreen Parent will buy 45% of the company’s stake which Karfunkel-Zyskind Family does not own presently for $2.7 billion. This acquisition will help AmTrust focus on long term growth objective rather than on short term results given it is becoming a private company. AmTrust’s leadership position in commercial small business, expansion of other segments and an impressive inorganic growth story poise it well for growth. It also aims to build an investment portfolio that returns in line with

  • [By Ethan Ryder]

    AmTrust Financial Services Inc (NASDAQ:AFSI) has been given a consensus recommendation of “Hold” by the ten ratings firms that are presently covering the firm, MarketBeat.com reports. One equities research analyst has rated the stock with a sell recommendation and seven have assigned a hold recommendation to the company. The average 1 year price objective among brokerages that have issued ratings on the stock in the last year is $14.63.

  • [By Lisa Levin]

    Some of the stocks that may grab investor focus today are:

    Wall Street expects Campbell Soup Company (NYSE: CPB) to report quarterly earnings at $0.61 per share on revenue of $2.14 billion before the opening bell. Campbell Soup shares fell 0.18 percent to $39.15 in after-hours trading.
    Applied Materials, Inc. (NASDAQ: AMAT) reported stronger-than-expected results for its second quarter, but issued weak sales outlook for the third quarter. Applied Materials shares fell 4.48 percent to $51.54 in the after-hours trading session.
    Analysts are expecting Deere & Company (NYSE: DE) to have earned $3.29 per share on revenue of $9.83 billion in the latest quarter. Deere will release earnings before the markets open. Deere shares dropped 1.23 percent to $145.00 in after-hours trading.
    AmTrust Financial Services Inc (NASDAQ: AFSI) shares rose over 5 percent in after-hours trading after a 13D filing from Carl Icahn shows a new 9.38 percent stake in the company. The filing also shows language from Icahn that strongly opposes a go-private transaction. AmTrust Financial shares climbed 5.81 percent to $14.21 in the after-hours trading session.

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Best Oil Stocks To Buy For 2019

U.S. equities mostly finished lower on Thursday while the Dow Jones Industrial Average inched higher — by four tenths of a point — to a new record high. For the average investor, all the focus will be on the Dow’s seventh consecutive gain. Below the surface, however, ominous signs continue to grow with the market flashing another “Hindenburg Omen” signal in the latest in a cluster of signals warning that breadth is fading away as buying interest grows increasingly narrow.

Headlines were preoccupied with palace intrigue out of Washington on reports Special Council Robert Mueller has impaneled a grand jury in the Russia probe. This was widely viewed as an intensification of the investigation.

In the end, the Dow Jones gained a fraction, the S&P 500 lost 0.2%, the Nasdaq Composite lost 0.4% and the Russell 2000 lost 0.5%. Treasury bonds strengthened, the dollar was mixed, gold lost 0.3% and crude oil fell 1.1% to reverse early session strength. That boosted the ProShares UltraShort Crude Oil (NYSEARCA:SCO) recommended to Edge subscribers to a gain of nearly 3%.

Best Oil Stocks To Buy For 2019: AmTrust Financial Services, Inc.(AFSI)

Advisors’ Opinion:

  • [By Benzinga News Desk]

    Carl Icahn fired off a letter to the board of AmTrust Financial Services (NASDAQ: AFSI) Thursday, blasting the firm for pursuing an “opportunistic going-private transaction” that would squeeze out minority shareholders: Link

  • [By Joseph Griffin]

    These are some of the media stories that may have effected Accern’s scoring:

    Get Encana alerts:

    Should You Listen to This Stock? Encana Corporation (ECA) moves 51.44% away from One Year Low (nasdaqchronicle.com) Hot Mover of the Day – Encana Corporation (NYSE:ECA) (thestockgem.com) Enrapturing Stocks: Encana Corporation, (NYSE: ECA), AmTrust Financial Services, Inc., (NASDAQ: AFSI) (globalexportlines.com) Analysts, Options Traders Love This Lesser-Known Energy Stock (schaeffersresearch.com) Encana Corp (ECA) Expected to Announce Quarterly Sales of $1.12 Billion (americanbankingnews.com)

    ECA traded up $0.27 on Thursday, hitting $12.47. 9,071,326 shares of the stock were exchanged, compared to its average volume of 9,380,907. Encana has a 12 month low of $8.01 and a 12 month high of $14.31. The company has a quick ratio of 1.16, a current ratio of 1.16 and a debt-to-equity ratio of 0.62. The stock has a market capitalization of $11.70 billion, a price-to-earnings ratio of 29.00, a P/E/G ratio of 1.98 and a beta of 2.00.

  • [By Ethan Ryder]

    Keefe, Bruyette & Woods reissued their $14.58 rating on shares of AmTrust Financial Services (NASDAQ:AFSI) in a research report report published on Wednesday. They currently have a $14.75 price target on the insurance provider’s stock.

  • [By Ethan Ryder]

    AmTrust Financial Services Inc (NASDAQ:AFSI) has been given a consensus recommendation of “Hold” by the ten ratings firms that are presently covering the firm, MarketBeat.com reports. One equities research analyst has rated the stock with a sell recommendation and seven have assigned a hold recommendation to the company. The average 1 year price objective among brokerages that have issued ratings on the stock in the last year is $14.63.

Best Oil Stocks To Buy For 2019: Newfield Exploration Company(NFX)

Advisors’ Opinion:

  • [By Chris Lange]

    The S&P 500 stock posting the largest daily percentage loss ahead of the close Tuesday was Newfield Exploration Company (NYSE: NFX) which traded down nearly 5% at $23.22. The stock’s 52-week range is $22.96 to $37.61. Volume was 5.2 million compared to the daily average volume of 3.3 million.

  • [By VantagePoint]

    Newfield Exploration Company (NYSE: NFX) just had a bearish crossover on Friday, according to the chart. The predicted 72-hour moving average crossed below the simple 10-day moving average. If Monday's price action holds, that will serve as a confirmation the negative trend. 

  • [By Matthew DiLallo]

    The IEA’s forecast bodes well for oil stocks, especially those that have underperformed during the rally over the past year. Two that stand out are Newfield Exploration (NYSE:NFX) and Apache (NYSE:APA), since both have lost value even though oil has been red-hot. Because of that, they trade at dirt cheap valuations versus their peers. That underperformance doesn’t make sense given the growth these companies can deliver at much lower oil prices.

Best Oil Stocks To Buy For 2019: EverBank Financial Corp.(EVER)

Advisors’ Opinion:

  • [By Paul Ausick]

    Everquote Inc. (NASDAQ: EVER) raised $84 million selling 4.7 million shares at $18, above the expected range of $15 to $17. Shares closed flat on the first day of trading and closed the week up 1%.

Top Medical Stocks To Buy For 2019

Quick Take

Scholar Rock Holding (SRRK) intends to raise $75 million in an IPO of its common stock, according to an SEC regulatory filing.

The company is advancing a pipeline of drug treatment candidates for muscle-wasting and cancer diseases.

While SRRK has a promising collaboration with Janssen, it is extremely early stage.

Company & Technology

Cambridge, Massachusetts-based Scholar Rock was founded in 2012 based on technologies developed in conjunction with Childrens Medical Center Corporation.

Management is headed by CEO Nagesh Mahanthappa, who has been with the firm as founding employee and was previously VP Corporate Development and Operations at Avila Therapeutics and held positions at Alnylam Pharmaceuticals.

Top Medical Stocks To Buy For 2019: Cytokinetics, Incorporated(CYTK)

Advisors’ Opinion:

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Cytokinetics (CYTK)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    Cytokinetics (NASDAQ:CYTK) had its price target cut by investment analysts at Piper Jaffray Companies to $13.00 in a note issued to investors on Monday. The firm currently has an “overweight” rating on the biopharmaceutical company’s stock. Piper Jaffray Companies’ price objective would indicate a potential upside of 55.69% from the stock’s previous close.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Cytokinetics (CYTK)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top Medical Stocks To Buy For 2019: AmTrust Financial Services, Inc.(AFSI)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Keefe, Bruyette & Woods reissued their $14.58 rating on shares of AmTrust Financial Services (NASDAQ:AFSI) in a research report report published on Wednesday. They currently have a $14.75 price target on the insurance provider’s stock.

  • [By Logan Wallace]

    National General (NASDAQ: NGHC) and AmTrust Financial Services (NASDAQ:AFSI) are both mid-cap finance companies, but which is the better stock? We will contrast the two companies based on the strength of their earnings, institutional ownership, profitability, analyst recommendations, risk, valuation and dividends.

  • [By Benzinga News Desk]

    Carl Icahn fired off a letter to the board of AmTrust Financial Services (NASDAQ: AFSI) Thursday, blasting the firm for pursuing an “opportunistic going-private transaction” that would squeeze out minority shareholders: Link

  • [By Lisa Levin]

    Some of the stocks that may grab investor focus today are:

    Wall Street expects Campbell Soup Company (NYSE: CPB) to report quarterly earnings at $0.61 per share on revenue of $2.14 billion before the opening bell. Campbell Soup shares fell 0.18 percent to $39.15 in after-hours trading.
    Applied Materials, Inc. (NASDAQ: AMAT) reported stronger-than-expected results for its second quarter, but issued weak sales outlook for the third quarter. Applied Materials shares fell 4.48 percent to $51.54 in the after-hours trading session.
    Analysts are expecting Deere & Company (NYSE: DE) to have earned $3.29 per share on revenue of $9.83 billion in the latest quarter. Deere will release earnings before the markets open. Deere shares dropped 1.23 percent to $145.00 in after-hours trading.
    AmTrust Financial Services Inc (NASDAQ: AFSI) shares rose over 5 percent in after-hours trading after a 13D filing from Carl Icahn shows a new 9.38 percent stake in the company. The filing also shows language from Icahn that strongly opposes a go-private transaction. AmTrust Financial shares climbed 5.81 percent to $14.21 in the after-hours trading session.

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

  • [By Lisa Levin] Gainers
    Shineco, Inc. (NASDAQ: TYHT) rose 34.7 percent to $2.29 in pre-market trading following Q3 results. Shineco posted Q3 earnings of $0.21 per share on sales of $13.3 million.
    Carver Bancorp, Inc. (NASDAQ: CARV) rose 15.8 percent to $12.74 in pre-market trading after surging 201.37 percent on Thursday.
    LiveXLive Media, Inc. (NASDAQ: LIVX) shares rose 11.5 percent to $7.75 in pre-market trading after climbing 64.50 percent on Thursday.
    Eiger BioPharmaceuticals, Inc. (NASDAQ: EIGR) rose 9 percent to $18.30 in pre-market trading after climbing 41.77 percent on Thursday.
    AmTrust Financial Services Inc (NASDAQ: AFSI) rose 6.2 percent to $14.25 in pre-market trading after a 13D filing from Carl Icahn shows a new 9.38 percent stake in the company. The filing also shows language from Icahn that strongly opposes a go-private transaction.
    Cerner Corporation (NASDAQ: CERN) rose 5.6 percent to $64.02 in pre-market trading after the Department of Veterans Affairs reported an agreement with Cerner Government Services, Inc. to provide seamless care for veterans.
    PetroChina Company Limited (NYSE: PTR) shares rose 5.3 percent to $82.05 in pre-market trading.
    TC PipeLines, LP (NYSE: TCP) shares rose 5.2 percent to $26.59 in the pre-market trading session.
    IQVIA Holdings Inc. (NYSE: IQV) shares rose 4.8 percent to $102.50 in pre-market trading as the company pulled secondary offering 'in light of recent market conditions'.
    Axon Enterprise, Inc. (NASDAQ: AAXN) rose 4.5 percent to $59.70 in pre-market trading. On Thursday, Axon priced its 4.3 million share offering of common stock at $53 per share.
    The Trade Desk, Inc. (NASDAQ: TTD) rose 4.5 percent to $84 in pre-market trading.
    PetIQ Inc (NASDAQ: PETQ) rose 3.9 percent to $18.96 in pre-market trading after a 13G filing shows a new 5.05 percent stake by the State of New Jersey's Division of Investment.
    Mattel, Inc. (NASDAQ: MAT) shares rose 3.7 percent to $15.85 in pre-market

Top Medical Stocks To Buy For 2019: Bonanza Creek Energy, Inc.(BCEI)

Advisors’ Opinion:

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Bonanza Creek Energy (BCEI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shanthi Rexaline]

    Crude oil prices continue to remain bullish, brightening the prospects of oil and related companies. Bonanza Creek Energy Inc (NYSE: BCEI), an oil and natural gas exploration and production company that emerged from Chapter 11 in April 2017, could also benefit from an improved cost structure, according to Imperial Capital. 

  • [By Joseph Griffin]

    Bonanza Creek Energy (NYSE:BCEI) was upgraded by equities research analysts at ValuEngine from a “strong sell” rating to a “sell” rating in a research report issued to clients and investors on Monday.

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Bonanza Creek Energy (BCEI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Bonanza Creek Energy (BCEI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top Medical Stocks To Buy For 2019: Clarke(t)

Advisors’ Opinion:

  • [By ]

    Dish Network Corp. (NASDAQ: DISH) is commonly known as the second fiddle to AT&T (NYSE: T) satellite service DirecTV, with around 11 million subscribers to DirecTV’s 25.36 million. With the growth of streaming, it’s no surprise that satellite television is a maturing business. Naturally, both companies have joined the streaming brawl. Dish with Sling and AT&T with its DirectNow service.

  • [By Adam Levy]

    T-Mobile (NASDAQ:TMUS) and Sprint (NYSE:S) recently submitted their public interest statement to the FCC about their proposed merger. In the document, the two companies present how their merger will benefit consumers. But further down, about 100 pages in, they explain that neither company can continue down the path they’ve been on, aggressively pursuing market share from AT&T (NYSE:T) and Verizon (NYSE:VZ).

  • [By Adam Levy]

    AT&T (NYSE:T) has nearly 1.5 million DIRECTV Now subscribers as of the end of the first quarter. The company’s over-the-top linear TV streaming service has grown faster than competitors like DISH Network’s (NASDAQ:DISH) Sling TV, Sony’s (NYSE:SNE) PlayStation Vue, or Hulu Live. It seems like only a matter of time before DIRECTV Now’s subscriber base surpasses Sling TV’s 2.3 million subscribers to become the most popular streaming TV service.

  • [By Keith Speights]

    And if you do like dividends, you should especially love three stocks: AbbVie (NYSE:ABBV), AT&T (NYSE:T), and Welltower (NYSE:WELL). Here’s what makes these dividend stocks really attractive to income-seeking investors.

Top 10 Warren Buffett Stocks To Buy Right Now

Warren Buffett and Jamie Dimon want companies to stop giving quarterly earnings forecasts and focus on the long term. Even investors seeking short-term gains might want to heed their point of view.

You’d think that providing a forecast every three months would make a company’s results more predictable. But since 2016, S&P 500 Index members that provide quarterly outlooks ended up reporting more surprises — or a wider gap between earnings and estimates — than the index as a whole. The group of companies that gave guidance only got closer to the consensus in two of the nine calendar quarters.

Bad Advice

Quarterly guidance has resulted in bigger earnings surprises since 2016

Source: Bloomberg

.chart-js { display: none; }

“Quarterly results are a piece of the investment mosaic, but we find little value in quarterly guidance for active managers performing their own research,” said Christopher Hillary, chief executive officer and portfolio manager at Denver-based Roubaix Capital, the $112 million hedge fund firm that focuses on small-cap stocks. “Long-term goals are a more useful tool in evaluating a business, as well as a means of holding the management and board accountable.”

Top 10 Warren Buffett Stocks To Buy Right Now: Blueprint Medicines Corporation(BPMC)

Advisors’ Opinion:

  • [By Todd Campbell]

    The big thing to watch this week will be how investors view Loxo’s results in comparison to results presented earlier this year by Blueprint Medicines (NASDAQ:BPMC). Blueprint’s BLU-667 also targets RET-fusions and at the American Association for Cancer Research meeting in April, Blueprint revealed a preliminary overall response rate of 50% for NSCLC and 40% for MTC. It’s bad science to compare unrelated trials, so investors might be best off viewing Loxo and Blueprint’s data as evidence that they’re both working on a winning approach.

  • [By Shane Hupp]

    A number of hedge funds and other institutional investors have recently added to or reduced their stakes in BPMC. Zurcher Kantonalbank Zurich Cantonalbank grew its position in Blueprint Medicines by 57.3% in the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 1,866 shares of the biotechnology company’s stock valued at $141,000 after acquiring an additional 680 shares in the last quarter. QS Investors LLC acquired a new position in Blueprint Medicines in the 4th quarter valued at about $173,000. First Mercantile Trust Co. acquired a new position in Blueprint Medicines in the 4th quarter valued at about $183,000. Tower Research Capital LLC TRC grew its position in Blueprint Medicines by 942.7% in the 4th quarter. Tower Research Capital LLC TRC now owns 2,513 shares of the biotechnology company’s stock valued at $190,000 after acquiring an additional 2,272 shares in the last quarter. Finally, Public Employees Retirement Association of Colorado acquired a new position in Blueprint Medicines in the 4th quarter valued at about $227,000. 97.79% of the stock is owned by institutional investors.

    COPYRIGHT VIOLATION NOTICE: “BidaskClub Downgrades Blueprint Medicines (BPMC) to Hold” was posted by Ticker Report and is the sole property of of Ticker Report. If you are accessing this report on another site, it was illegally stolen and reposted in violation of international trademark & copyright law. The legal version of this report can be read at www.tickerreport.com/banking-finance/3356624/bidaskclub-downgrades-blueprint-medicines-bpmc-to-hold.html.

    Blueprint Medicines Company Profile

  • [By Brian Orelli]

    On the downside, Blueprint Medicines (NASDAQ:BPMC)also is developing a RET targeting drug called BLU-667. The company doesn’t seem to be presenting additional data at ASCO, likely because it just released data last month at the American Association for Cancer Research meeting. While it’s very hard to make apples-to-apples comparisons across phase 1 trials, BLU-667 doesn’t look quite as active, with ORR of 50% percent in patients with NSCLC and 40% in patients with medullary thyroid cancer.

  • [By Todd Campbell]

    Investors should also keep their enthusiasm in check because Loxo Oncology isn’t alone in targeting TRK fusion and RET mutations:Roche Holdings (NASDAQOTH:RHHBY) could challenge it in TRK fusions and Blueprint Medicines (NASDAQ:BPMC) could compete with it in RET mutations.

  • [By Todd Campbell]

    In this clip of The Motley Fool’s Industry Focus Healthcare, host Kristine Harjes is joined by Motley Fool contributor Todd Campbell to discuss LOXO-292’s opportunity and how competitor Blueprint Medicines (NASDAQ:BPMC) is challenging it. Also, the two analysts discuss why shares in Abiomed, Inc. (NASDAQ:ABMD) are soaring higher and if this is a high-priced stock that investors should embrace or ignore.

Top 10 Warren Buffett Stocks To Buy Right Now: AmTrust Financial Services, Inc.(AFSI)

Advisors’ Opinion:

  • [By Logan Wallace]

    National General (NASDAQ: NGHC) and AmTrust Financial Services (NASDAQ:AFSI) are both mid-cap finance companies, but which is the better stock? We will contrast the two companies based on the strength of their earnings, institutional ownership, profitability, analyst recommendations, risk, valuation and dividends.

  • [By Ethan Ryder]

    Keefe, Bruyette & Woods reissued their $14.58 rating on shares of AmTrust Financial Services (NASDAQ:AFSI) in a research report report published on Wednesday. They currently have a $14.75 price target on the insurance provider’s stock.

  • [By Lisa Levin] Gainers
    Shineco, Inc. (NASDAQ: TYHT) rose 34.7 percent to $2.29 in pre-market trading following Q3 results. Shineco posted Q3 earnings of $0.21 per share on sales of $13.3 million.
    Carver Bancorp, Inc. (NASDAQ: CARV) rose 15.8 percent to $12.74 in pre-market trading after surging 201.37 percent on Thursday.
    LiveXLive Media, Inc. (NASDAQ: LIVX) shares rose 11.5 percent to $7.75 in pre-market trading after climbing 64.50 percent on Thursday.
    Eiger BioPharmaceuticals, Inc. (NASDAQ: EIGR) rose 9 percent to $18.30 in pre-market trading after climbing 41.77 percent on Thursday.
    AmTrust Financial Services Inc (NASDAQ: AFSI) rose 6.2 percent to $14.25 in pre-market trading after a 13D filing from Carl Icahn shows a new 9.38 percent stake in the company. The filing also shows language from Icahn that strongly opposes a go-private transaction.
    Cerner Corporation (NASDAQ: CERN) rose 5.6 percent to $64.02 in pre-market trading after the Department of Veterans Affairs reported an agreement with Cerner Government Services, Inc. to provide seamless care for veterans.
    PetroChina Company Limited (NYSE: PTR) shares rose 5.3 percent to $82.05 in pre-market trading.
    TC PipeLines, LP (NYSE: TCP) shares rose 5.2 percent to $26.59 in the pre-market trading session.
    IQVIA Holdings Inc. (NYSE: IQV) shares rose 4.8 percent to $102.50 in pre-market trading as the company pulled secondary offering 'in light of recent market conditions'.
    Axon Enterprise, Inc. (NASDAQ: AAXN) rose 4.5 percent to $59.70 in pre-market trading. On Thursday, Axon priced its 4.3 million share offering of common stock at $53 per share.
    The Trade Desk, Inc. (NASDAQ: TTD) rose 4.5 percent to $84 in pre-market trading.
    PetIQ Inc (NASDAQ: PETQ) rose 3.9 percent to $18.96 in pre-market trading after a 13G filing shows a new 5.05 percent stake by the State of New Jersey's Division of Investment.
    Mattel, Inc. (NASDAQ: MAT) shares rose 3.7 percent to $15.85 in pre-market

Top 10 Warren Buffett Stocks To Buy Right Now: Magellan Midstream Partners L.P.(MMP)

Advisors’ Opinion:

  • [By John Bromels]

    Three companies that the market has walloped areApache Corporation(NYSE:APA),Magellan Midstream Partners(NYSE:MMP), andGeneral Motors(NYSE:GM). Here’s why these stocks look like bargains, and why today might be a good time to scoop up some shares.

  • [By Reuben Gregg Brewer]

    For an example of just how important this is, take a look at the graph below. Midstream companies ONEOK Inc. (NYSE:OKE), Magellan Midstream Partners LP(NYSE:MMP), and Enterprise Products Partners L.P. (NYSE:EPD) have each increased their disbursements for more than a decade. However, there is a difference in the growth rates over time. Enterprise’s 10-year annualized distribution increase was 5.7%, Magellan’s was 10.9%, and ONEOK’s dividend rose at an annualized 16.1% clip. Just a few percentage points here makes a huge difference in the growth of the disbursement over time, as the chart below clearly shows.

  • [By Reuben Gregg Brewer]

    The midstream partnership sector is deeply out of favor today, despite the fact that these companies provide vital services moving and processing oil and natural gas. For conservative investors, Enterprise Products Partners L.P. (NYSE:EPD) and Magellan Midstream Partners, L.P. (NYSE:MMP) are two high-yield stocks that appear to be on sale today, still off roughly 30% and 20% from their 2014 highs, respectively. Here’s what you need to know to decide if Enterprise or Magellan is the better buy for you.

Top 10 Warren Buffett Stocks To Buy Right Now: Haynes International, Inc.(HAYN)

Advisors’ Opinion:

  • [By Ethan Ryder]

    BidaskClub downgraded shares of Haynes International (NASDAQ:HAYN) from a hold rating to a sell rating in a report released on Saturday morning.

    Several other brokerages have also recently issued reports on HAYN. Zacks Investment Research cut Haynes International from a buy rating to a hold rating and set a $50.00 target price on the stock. in a report on Tuesday, March 13th. ValuEngine raised Haynes International from a hold rating to a buy rating in a report on Thursday, April 19th. One research analyst has rated the stock with a sell rating, one has given a hold rating and three have issued a buy rating to the company’s stock. Haynes International currently has an average rating of Hold and a consensus target price of $35.00.

Top 10 Warren Buffett Stocks To Buy Right Now: STAAR Surgical Company(STAA)

Advisors’ Opinion:

  • [By Joseph Griffin]

    STAAR Surgical (NASDAQ:STAA) hit a new 52-week high and low during mid-day trading on Friday . The company traded as low as $28.55 and last traded at $28.42, with a volume of 6590 shares changing hands. The stock had previously closed at $27.80.

  • [By Lisa Levin] Gainers
    Euro Tech Holdings Company Limited (NASDAQ: CLWT) shares jumped 155.56 percent to close at $5.75 on Thursday.
    Inspire Medical Systems, Inc. (NYSE: INSP) shares gained 56.12 percent to close at $24.98. Inspire Medical went public Thursday on the New York Stock Exchange. The company issued 6.75 million shares priced at $16 each.
    Presbia PLC (NASDAQ: LENS) shares rose 53.02 percent to close at $3.55.
    Integrated Media Technology Limited (NASDAQ: IMTE) shares rose 46.29 percent to close at $32.11. The nano-cap low-float stock skyrocketed over 1,300 percent on Wednesday on no company specific news which would support the surge. The move higher is consistent with what was seen in other low-float stocks over the past few months.
    Technical Communications Corporation (NASDAQ: TCCO) climbed 27.78 percent to close at $5.75.
    STAAR Surgical Company (NASDAQ: STAA) shares gained 26.27 percent to close at $21.15 after reporting upbeat Q1 results.
    Sharing Economy International Inc. (NASDAQ: SEII) shares jumped 22.16 percent to close at $4.30 on Thursday after gaining 9.32 percent on Wednesday.
    China Advanced Construction Materials Group, Inc. (NASDAQ: CADC) rose 20.45 percent to close at $2.65 on Thursday.
    YRC Worldwide Inc. (NASDAQ: YRCW) surged 18.36 percent to close at $9.99 following upbeat quarterly earnings.
    MYR Group Inc. (NASDAQ: MYRG) jumped 17.68 percent to close at $35.74 after the company posted strong Q1 earnings.
    Xspand Products Lab Inc (NASDAQ: XSPL) jumped 17.4 percent to close at $5.87. Xspand Products priced its IPO at $5 per share.
    Coherus BioSciences, Inc. (NASDAQ: CHRS) shares rose 17.32 percent to close at $14.90. Coherus BioSciences reported resubmission of BLA for CHS-1701.
    Rudolph Technologies, Inc. (NASDAQ: RTEC) shares gained 17.17 percent to close at $31.05 following upbeat quarterly earnings.
    The Meet Group, Inc. (NASDAQ: MEET) gained 16.02 percent to close at $2.68 following Q1 earnings.
    Ca
  • [By Joseph Griffin]

    STAAR Surgical (NASDAQ:STAA) was upgraded by equities researchers at TheStreet from a “c” rating to a “b-” rating in a research report issued on Monday.

  • [By Lisa Levin]

    STAAR Surgical Company (NASDAQ: STAA) shares shot up 28 percent to $21.40 after reporting upbeat Q1 results.

    Shares of Integrated Media Technology Limited (NASDAQ: IMTE) got a boost, shooting up 57 percent to $34.52. The nano-cap low-float stock skyrocketed over 1,300 percent on Wednesday on no company specific news which would support the surge. The move higher is consistent with what was seen in other low-float stocks over the past few months.

  • [By Lisa Levin]

    STAAR Surgical Company (NASDAQ: STAA) shares shot up 26 percent to $21.03 after reporting upbeat Q1 results.

    Shares of Integrated Media Technology Limited (NASDAQ: IMTE) got a boost, shooting up 56 percent to $34.2425. The nano-cap low-float stock skyrocketed over 1,300 percent on Wednesday on no company specific news which would support the surge. The move higher is consistent with what was seen in other low-float stocks over the past few months.

Top 10 Warren Buffett Stocks To Buy Right Now: ePlus Inc.(PLUS)

Advisors’ Opinion:

  • [By Lisa Levin]

     

    Companies Reporting After The Bell
    Ross Stores, Inc. (NASDAQ: ROST) is projected to post quarterly earnings at $1.07 per share on revenue of $3.54 billion.
    Autodesk, Inc. (NASDAQ: ADSK) is expected to post quarterly earnings at $0.03 per share on revenue of $557.65 million.
    Gap, Inc. (NYSE: GPS) is projected to post quarterly earnings at $0.46 per share on revenue of $3.60 billion.
    Quality Systems, Inc. (NASDAQ: QSII) is estimated to post quarterly earnings at $0.13 per share on revenue of $131.95 million.
    Splunk Inc. (NASDAQ: SPLK) is expected to post quarterly loss at $0.09 per share on revenue of $297.67 million.
    Shoe Carnival, Inc. (NASDAQ: SCVL) is projected to post quarterly earnings at $0.71 per share on revenue of $262.02 million.
    Deckers Outdoor Corporation (NYSE: DECK) is expected to post quarterly earnings at $0.19 per share on revenue of $375.41 million.
    Zoe's Kitchen, Inc. (NYSE: ZOES) is estimated to post quarterly loss at $0.01 per share on revenue of $105.30 million.
    DXC Technology Company (NYSE: DXC) is expected to post quarterly earnings at $2.23 per share on revenue of $6.12 billion.
    8×8, Inc. (NASDAQ: EGHT) is estimated to post quarterly loss at $0.05 per share on revenue of $76.93 million.
    Viasat, Inc. (NASDAQ: VSAT) is projected to post quarterly loss at $0.45 per share on revenue of $424.46 million.
    ePlus inc. (NASDAQ: PLUS) is estimated to post quarterly earnings at $1.01 per share on revenue of $1.60 billion.
    Lions Gate Entertainment Corp. (NYSE: LGF.A) is expected to post quarterly loss at $0.04 per share on revenue of $1.04 billion.
    Agilysys, Inc. (NASDAQ: AGYS) is estimated to post quarterly loss at $0.08 per share on revenue of $32.58 million.
    Nutanix, Inc. (NASDAQ: NTNX) is estimated to post quarterly loss at $0.19 per share on revenue of $278.98 million.
    Veeva Systems Inc. (NYSE: VEEV) is projected to post quarterly earnings at $0.31 per share on revenue

  • [By Ethan Ryder]

    Tech Data (NASDAQ: TECD) and ePlus (NASDAQ:PLUS) are both retail/wholesale companies, but which is the better business? We will compare the two businesses based on the strength of their valuation, institutional ownership, risk, dividends, analyst recommendations, profitability and earnings.

  • [By Stephan Byrd]

    Teacher Retirement System of Texas decreased its position in ePlus (NASDAQ:PLUS) by 36.2% during the 1st quarter, according to its most recent filing with the SEC. The institutional investor owned 3,093 shares of the software maker’s stock after selling 1,754 shares during the period. Teacher Retirement System of Texas’ holdings in ePlus were worth $240,000 as of its most recent filing with the SEC.

  • [By ]

    “When and where will all of the many conflicts of interest be listed by the 13 Angry Democrats (plus) working on the Witch Hunt Hoax,” Trump said of the probe on Twitter Thursday. “There has never been a group of people on a case so biased or conflicted. It is all a Democrat Excuse for LOSING the Election.”

  • [By Max Byerly]

    Uniplan Investment Counsel Inc. reduced its stake in ePlus (NASDAQ:PLUS) by 1.1% during the 1st quarter, HoldingsChannel reports. The fund owned 116,594 shares of the software maker’s stock after selling 1,335 shares during the period. Uniplan Investment Counsel Inc.’s holdings in ePlus were worth $9,059,000 at the end of the most recent reporting period.

Top 10 Warren Buffett Stocks To Buy Right Now: Nuveen Tax-Advantaged Total Return Strategy Fund(JTA)

Advisors’ Opinion:

  • [By Max Byerly]

    Wells Fargo & Company MN decreased its holdings in Nuveen Tax Advantaged Total Re (NYSE:JTA) by 48.2% in the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 10,813 shares of the investment management company’s stock after selling 10,055 shares during the period. Wells Fargo & Company MN owned approximately 0.08% of Nuveen Tax Advantaged Total Re worth $150,000 as of its most recent SEC filing.

Top 10 Warren Buffett Stocks To Buy Right Now: InspireMD, Inc.(NSPR)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Sigma Labs, Inc. (NASDAQ: SGLB) shares rose 90.9 percent to $2.52. Sigma Labs demonstrated proof of concept for closed loop quality control during metal additive manufacturing.
    Oragenics, Inc. (NYSE: OGEN) shares surged 58.4 percent to $1.9005 after the company’s AG013 for oral mucositis in head and neck cancer patients showed favorable safety profile in mid-stage OM study.
    Dick's Sporting Goods, Inc. (NYSE: DKS) shares climbed 23.2 percent to $37.5370 after the company reported upbeat Q1 earnings and raised FY18 earnings outlook.
    Summer Infant, Inc. (NASDAQ: SUMR) rose 21.9 percent to $1.17 after announcing commitment for $60 million credit facility from Bank of America and $17.5 million term loan from Pathlight Capital.
    TapImmune, Inc. (NASDAQ: TPIV) jumped 18.8 percent to $4.87. WBB Securities upgraded TapImmune from Speculative Buy to Buy.
    Movado Group, Inc. (NYSE: MOV) gained 17.2 percent to $49.45 after the company reported better-than-expected Q1 results and raised its guidance.
    ASLAN Pharmaceuticals Limited (NASDAQ: ASLN) jumped 16.2 percent to $7.96. BTIG Research initiated coverage on ASLAN Pharmaceuticals with a Buy rating.
    Legacy Reserves LP (NASDAQ: LGCY) rose 15.5 percent to $5.6011.
    InspireMD, Inc. (NYSE: NSPR) gained 13.3 percent to $1.36 following PR announcing sustained benefit of CGuard EPS.
    Immutep Limited (NASDAQ: IMMP) shares climbed 13.2 percent to $2.7724 after the company reported new data from its ongoing TACTI-mel Phase I trial, which evaluated the combination of eftilagimod alpha, its lead compound, with Merck & Co., Inc. (NYSE: MRK)'s Keytruda in unresectable or metastatic melanoma patients, who have had a suboptimal response or had disease progression with keytruda monotherapy..
    SpartanNash Co (NASDAQ: SPTN) rose 12.2 percent to $21.20 after the company reported upbeat earnings for its first quarter on Tuesday.
    Amtech Systems, Inc. (NASDAQ: ASYS) rose 12.1 percent to
  • [By Lisa Levin] Gainers
    Oragenics, Inc. (NYSE: OGEN) shares surged 66.67 percent to close at $2.00 on Wednesday after the company’s AG013 for oral mucositis in head and neck cancer patients showed favorable safety profile in mid-stage OM study.
    Sigma Labs, Inc. (NASDAQ: SGLB) shares jumped 49.24 percent to close at $1.97 on Wednesday. Sigma Labs demonstrated proof of concept for closed loop quality control during metal additive manufacturing.
    ASLAN Pharmaceuticals Limited (NASDAQ: ASLN) rose 34.45 percent to close at $9.21. BTIG Research initiated coverage on ASLAN Pharmaceuticals with a Buy rating.
    Dick's Sporting Goods, Inc. (NYSE: DKS) shares rose 25.82 percent to close at $38.35 after the company reported upbeat Q1 earnings and raised FY18 earnings outlook.
    TapImmune, Inc. (NASDAQ: TPIV) rose 24.15 percent to close at $5.09. WBB Securities upgraded TapImmune from Speculative Buy to Buy.
    Legacy Reserves LP (NASDAQ: LGCY) jumped 23.3 percent to close at $5.98 on Wednesday.
    Summer Infant, Inc. (NASDAQ: SUMR) gained 22.92 percent to close at $1.18 after announcing commitment for $60 million credit facility from Bank of America and $17.5 million term loan from Pathlight Capital.
    Cloud Peak Energy Inc. (NYSE: CLD) rose 21.95 percent to close at $4.00.
    SpartanNash Co (NASDAQ: SPTN) gained 21.4 percent to close at $22.92 after the company reported upbeat earnings for its first quarter on Tuesday.
    Motus GI Holdings, Inc. (NASDAQ: MOTS) rose 17.14 percent to close at $5.40.
    Movado Group, Inc. (NYSE: MOV) gained 16.59 percent to close at $49.20 after the company reported better-than-expected Q1 results and raised its guidance.
    Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) climbed 15.61 percent to close at $8.22. Oramed Pharma disclosed that its patent has been allowed in the US for oral administration of proteins.
    Dorian LPG Ltd. (NYSE: LPG) rose 14.89 percent to close at $8.41. Dorian LPG confirmed receipt of unsolicited proposal fr

Top 10 Warren Buffett Stocks To Buy Right Now: Industrias Bachoco, S.A. de C.V.(IBA)

Advisors’ Opinion:

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Industrias Bachoco (IBA)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Bachoco (IBA)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Bachoco (NYSE:IBA) declared a semiannual dividend on Thursday, April 26th, NASDAQ reports. Stockholders of record on Friday, May 11th will be given a dividend of 0.432 per share on Monday, May 21st. This represents a dividend yield of 1.53%. The ex-dividend date is Thursday, May 10th. This is a boost from Bachoco’s previous semiannual dividend of $0.42.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Industrias Bachoco (IBA)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Warren Buffett Stocks To Buy Right Now: Can-Fite Biopharma Ltd(CANF)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Co-Diagnostics, Inc. (NASDAQ: CODX) jumped 88 percent to $5.4500 after falling 13.17 percent on Thursday. Co-Diagnostics reported its participation in a research project with the Stanford University.
    Euro Tech Holdings Company Limited (NASDAQ: CLWT) climbed 40.3 percent to $5.40 after the company declared a $0.70 per share special dividend.
    Future FinTech Group Inc. (NASDAQ: FTFT) rose 27 percent to $2.73. Future FinTech disclosed a strategic transformation plan including expanding on current blockchain business while also becoming a blockchain incubator, investment and asset management, training, and management consulting.
    SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) gained 14.7 percent to $5.9522 after the company disclosed that its Phase 2b trial of NeuVax in combo with Trastuzumab in HER1+/2+ breast cancer patients met key clinical objectives.
    Lululemon Athletica Inc. (NASDAQ: LULU) shares climbed 14.6 percent to $120.4224 after the company reported better-than-expected results for its first quarter. The company also raised its FY18 earnings and sales guidance.
    FTE Networks, Inc. (NASDAQ: FTNW) gained 10.5 percent to $20.9399.
    T2 Biosystems, Inc. (NASDAQ: TTOO) rose 9 percent to $8.07. Leerink Swann upgraded T2 Biosystems from Market Perform to Outperform.
    Zuora, Inc. (NYSE: ZUO) shares rose 8.3 percent to $24.01 after the company reported upbeat Q1 earnings and issued strong outlook.
    VMware, Inc. (NYSE: VMW) rose 7.7 percent to $148.07 as the company reported stronger-than-expected results for its first quarter on Thursday.
    Ambac Financial Group, Inc. (NASDAQ: AMBC) gained 7.5 percent to $19.91. Ambac Financial will replace Integra Lifesciences Holdings in the S&P SmallCap 600 on Tuesday, June 5.
    Conatus Pharmaceuticals Inc. (NASDAQ: CNAT) gained 7 percent to $4.60.
    Kiniksa Pharmaceuticals, Ltd. (NASDAQ: KNSA) climbed 6.6 percent to $18.23.
    Franklin Street Properties Corp. (NYSE: FSP) gained 5.7 perce
  • [By Max Byerly]

    CAN-FITE BIOPHA/S (NYSEAMERICAN:CANF) saw a large drop in short interest in the month of June. As of June 29th, there was short interest totalling 302,241 shares, a drop of 14.1% from the June 15th total of 351,936 shares. Based on an average daily volume of 208,682 shares, the short-interest ratio is presently 1.4 days.

  • [By Lisa Levin] Gainers
    Euro Tech Holdings Company Limited (NASDAQ: CLWT) rose 18.2 percent to $4.55 in pre-market trading after the company declared a $0.70 per share special dividend.
    Co-Diagnostics, Inc. (NASDAQ: CODX) rose 11.7 percent to $3.24 in pre-market trading after falling 13.17 percent on Thursday. Co-Diagnostics reported its participation in a research project with the Stanford University.
    Abercrombie & Fitch Co. (NYSE: ANF) shares rose 8.6 percent to $25.95 in pre-market trading after the company posted upbeat Q1 results.
    Zuora, Inc. (NYSE: ZUO) shares rose 8 percent to $23.95 in pre-market trading after the company reported upbeat Q1 earnings and issued strong outlook.
    Lululemon Athletica Inc. (NASDAQ: LULU) shares rose 7.8 percent to $113.25 in pre-market trading after the company reported better-than-expected results for its first quarter. The company also raised its FY18 earnings and sales guidance.
    OPKO Health, Inc. (NYSE: OPK) rose 5.7 percent to $4.10 in pre-market trading.
    Lannett Company, Inc. (NYSE: LCI) rose 5.5 percent to $17.45 in pre-market trading following the FDA approval for Levofloxacin Oral Solution.
    Eversource Energy (NYSE: ES) shares rose 5 percent to $59.8 in pre-market trading.
    VMware, Inc. (NYSE: VMW) rose 4.6 percent to $143.74 in pre-market trading as the company reported stronger-than-expected results for its first quarter on Thursday.
    Energy Transfer Partners, L.P. (NYSE: ETP) rose 4.3 percent to $19.80 in pre-market trading after the company reported the Federal Energy Regulatory Commission approval to place Rover pipeline’s full Mainline B into service.
    T2 Biosystems, Inc. (NASDAQ: TTOO) rose 4.3 percent to $7.73 in pre-market trading after declining 4.26 percent on Thursday.
    Curis, Inc. (NASDAQ: CRIS) rose 4.3 percent to $2.90 in pre-market trading after jumping 21.93 percent on Thursday.
    Sasol Limited (NYSE: SSL) rose 4.2 percent to $37.91 in pre-market trading.
    Nucor Corporatio
  • [By Shane Hupp]

    Press coverage about Can-Fite Biopharma (NASDAQ:CANF) has trended somewhat positive this week, Accern reports. The research group identifies positive and negative news coverage by monitoring more than 20 million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Can-Fite Biopharma earned a media sentiment score of 0.24 on Accern’s scale. Accern also gave press coverage about the company an impact score of 45.2576556193403 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the near term.